期刊
CURRENT TREATMENT OPTIONS IN ONCOLOGY
卷 -, 期 -, 页码 -出版社
SPRINGER
DOI: 10.1007/s11864-023-01147-3
关键词
Neuroendocrine neoplasms; Minimally invasive biomarkers; NETest; Circulating tumor DNA; Circulating tumor cells
类别
Given the considerable heterogeneity in neuroendocrine neoplasms, there is a need for multiple biomarkers to capture different aspects of these tumors. Circulating biomarkers, such as NETest and ctDNA-based analysis, show promise in enhancing accuracy of diagnosis, prognosis determination, and therapy prediction and monitoring.
Given the considerable heterogeneity in neuroendocrine neoplasms (NENs), it appears unlikely that a sole biomarker exists capable of fully capturing all useful clinical aspects of these tumors. This is reflected in the abundant number of biomarkers presently available for the diagnosis, prognosis, and monitoring of NEN patients. Although assessment of immunohistochemical and radiological markers remains paramount and often obligatory, there has been a notable surge of interest in circulating biomarkers over the years given the numerous benefits associated with liquid biopsies. Currently, the clinic primarily relies on single-analyte assays such as the chromogranin A assay, but these are far from ideal because of limitations such as compromised sensitivity and specificity as well as a lack of standardization. Consequently, the quest for NEN biomarkers continued with the exploration of multianalyte markers, exemplified by the development of the NETest and ctDNA-based analysis. Here, an extensive panel of markers is simultaneously evaluated to identify distinct signatures that could enhance the accuracy of patient diagnosis, prognosis determination, and response to therapy prediction and monitoring. Given the promising results, the development and implementation of these multianalyte markers are expected to usher in a new era of NEN biomarkers in the clinic. In this review, we will outline both clinically implemented and more experimental circulating markers to provide an update on developments in this rapidly evolving field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据